Sign up to receive our news roundups

U.S. FDA Approves Moxidectin, WHO validates Trachoma Elimination in Ghana & Other NTD News

News roundup

This news roundup is a collection of headlines and other items on neglected tropical diseases, and does not reflect the work or the views of the Neglected Tropical Diseases Support Center.

Ghana Trachoma

Fusi, an opthalmic nurse screens communities in Yendi

RUTH MCDOWALL/SIGHTSAVERS

Lymphatic filariasis

Experts share recommendations to eliminate Lymphatic Filariasis at the 10th GAELF meeting

ET Healthworld
The 10th meeting of the Global Alliance to Eliminate Lymphatic Filariasis (GAELF) concluded in New Delhi with Joint Secretary, Ministry of Health & Family Welfare, Vikas Sheel urging all partners to come out of silos, integrate efforts and implement the filariasis elimination agenda to meet the 2020 global Lymphatic Filariasis elimination target.

Shri J P Nadda inaugurates 10th Meeting of Global Alliance to Eliminate Lymphatic Filariasis

Ministry of Health and Family Welfare Press Information Bureau (India)
Shri J P Nadda, Union Minister of Health and Family Welfare inaugurated the 10th meeting of Global Alliance to Eliminate Lymphatic Filariasis (GAELF), here today. At the event, Shri Nadda also gave away the GAELF awards to 11 countries- Cambodia, Cook Islands, Egypt, Maldives, Marshall Islands, Niue, Sri Lanka, Thailand, Togo, Tonga and Vanuatu, for successfully interrupting the transmission. The Union Health Minister also released the Accelerated Plan for Elimination of Lymphatic Filariasis (LF) 2018 for India.

100 out of 256 endemic districts have achieved LF elimination targets: Nadda

India Today
The Union minister said that with the concerted efforts of "government, state governments and development partners, 100 districts out of total 256 endemic districts have achieved elimination targets and stopped Mass Drug Administration after successful validation by Transmission Assessment Survey (TAS) and are under post MDA surveillance".

Maharashtra: New treatment strategy to eliminate Lymphatic Filariasis

Anuradha Mascarenhas
Indian Express
At a meeting held in Delhi on Wednesday, Union Health Minister J P Nadda launched an accelerated Plan for elimination of Lymphatic Filariasis and phased adoption of a new treatment strategy for India at the global meet. “We need to interrupt the transmission of the disease,” said Dr Eric Ottesen, director, Neglected Tropical Diseases Support Centre (NTD-SC), Task Force for Global Health.

[OPINION] Handling a threat

N.K. Ganguly and S.L. Hoti
The Hindu
Elimination efforts do not end with achieving the desired results in [mass drug administration, or] MDA. The most traumatic impact of the disease is the suffering caused by the full-blown manifestation of filariasis in those who are infected. Morbidity management and disability prevention (MMDP) of lymphedema and hydrocele must assume greater importance so that the quality of life of affected individuals can be improved. It will be important to adopt innovative strategies that can be scaled up for India to create history and achieve another milestone by eliminating [lymphatic filariasis, or] LF.

Increasing evidence of low lymphatic filariasis prevalence in high risk Loa loa areas in Central and West Africa

Louise A. Kelly-Hope, Janet Hemingway, Mark J. Taylor and David H. Molyneux
Parasites & Vectors
Here we review the literature and present historical evidence, which uniformly highlight low or no prevalence of Wuchereria bancrofti infection and/or clinical [lymphatic filariasis, or] LF cases across five Central African countries, in more than 30 different geographical areas covering 280 individual sites and > 22,000 individuals tested within high risk Loa loa areas. This highlights the very limited information available on LF prevalence in Loa loa areas, and potentially has major policy implications, which could shift the focus towards revised mapping criteria to verify low or no W. bancrofti prevalence in high risk Loa loa areas.

Onchocerciasis

First new treatment for river blindness approved by U.S. FDA in 20 years

TDR
The United States Food and Drug Administration (FDA) has approved moxidectin as the first new treatment for river blindness in 20 years, adding new ammunition to the fight to eliminate this disabling disease. The FDA decision followed priority review of a new drug application for a neglected tropical disease submitted by the not-for-profit biopharmaceutical company Medicines Development for Global Health (MDGH). “It is a milestone toward our vision to have moxidectin made available to African countries to quicken the river blindness endgame,” says TDR Director John Reeder.

The Committee Renames the Prix Galien Pro Bono Humanum Award to recognize the global health leadership of Dr. Roy Vagelos

The Galien Foundation
PR Newswire
The Prix Galien USA Committee announced today that the Prix Galien Pro Bono Humanum Award for individual service to improve the state of human health will be renamed in honor of Dr. P. Roy Vagelos, Retired Chairman and CEO, Merck & Co., Inc. Chairman of the Board, Regeneron Pharmaceuticals. Dr. Vagelos won the Prix Galien in 1986 for his unprecedented decision as CEO of a major global pharmaceutical company to donate the drug Mectizan to patients in 34 countries to treat and prevent river blindness (onchocerciasis), a parasitic disease that ranks as a leading cause of preventable blindness in developing countries, for "as much and as long as necessary."

River Blindness: Sightsavers Commences Distribution Of Drugs In Kwara

Fatima Mohammed-Lawal
Sundiata Post (Nigeria)
Sight Savers, a Non Governmental Organization, has donated drugs for treating river blindness and other Neglected Tropical Diseases (NTDs) to some communities in Kwara. Mr Johnson Emmanuel, the Monitoring and Supervision Programme Assistant of Sight Savers, stated this on Thursday in Ilorin at the presentation of eight motor cycles to NTDs Coordinators in eight Local Government Areas of Kwara.

Schistosomiasis

Prevalence of Urinary Schistosomiasis and Efficacy of Praziquantel; a Case Study of School Pupils in Nigeria

Olajumoke Onifade et al.
South Asian Journal of Parasitology
In this study, urine samples were collected along with basic demographic information from 528 pupils from 3 primary schools in Oke-Igbo community of Ondo state, Nigeria. There was a significant difference in the prevalence rate between age groups and gender (P<0.05). There is need for more political commitment from the government to provide basic amenities such as toilet facilities, and pipe borne water to rural areas other than the usual chemotherapy if elimination is to be achieved.

Critical linkages between land use change and human health in the Amazon region: A scoping review

Molly Mastel et al.
PLOS One
Land use change (LUC) is a main cause of global environmental change, and is an important activity to be studied. Our research aims to examine the current state of evidence on the link between LUC and human health in the Amazon region . . . Only one paper discussed LUC related to dam power plants—these were associated with abundance of potential vector species of snail. These snails had the potential to spread Centerocestus formasus, schistosomiasis, and the parasite responsible for cercarial dermatitis.

A novel green approach for treatment of immature Schistosomiasis Mansoni infection in mice; Arabic gum (Acacia Senegal)

Rabab Selem et al.
bioRxiv
Schistosomiasis is one of the most socioeconomically exhausting parasitic infection in tropical and subtropical areas. Praziquantel (PZQ), the only common schistosocidal drug in use, is not efficient enough for treatment of immature infection. Arabic gum (AG) is a complex polysaccharide acts as anti-oxidant which modulates the inflammatory and/or immunological processes. This study explores for the first time, the antischistosomal properties of AG in mice infected with the immature stage of Schistosoma mansoni.

Schistosomiasis in immigrants, refugees and travellers in an Italian referral centre for tropical diseases

Valentina Marchese et al.
Infectious Diseases of Poverty
The aim of our study was to assess differences in demographic characteristics, clinical presentation, laboratory data and ultrasound findings between immigrants/visiting friends and relatives (VFR) from endemic countries (endemic group) and expatriates/travellers (non-endemic group). Symptoms, eosinophilia and abnormal ultrasound findings were present in about half of patients, without differences between groups.

Soil-Transmitted Helminthiasis

Epidemiology of soil transmitted Helminth infections in the middle-belt of Ghana, Africa

Dennis Adu-Gyasi et al.
Parasite Epidemiology and Control
This study was carried out to describe the distribution of helminth and malaria parasite infections in the middle-belt of Ghana in sub-Saharan Africa where disease burden, including anaemia is rife and helminths are perceived to be significant contributors of the burden. Proper sanitation, protective footwear, religion and good personal hygiene practices were found to influence helminth and hookworm prevalence in the area. Malaria parasite coinfection with helminths, especially hookworm infections increased 2-fold.

Longitudinal changes in the prevalence and intensity of soil-transmitted helminth infection following expanded MDA in Myanmar

Julia C. Dunn et al.
BioRxiv
In countries with endemic infection, such as Myanmar, the [mass drug administration, or] MDA coverage, who is targeted, and rates of reinfection in given environmental and social settings will determine how effective mass drug treatment is in suppressing transmission in the long-term. In this paper, data from an epidemiology study on STH, conducted between June 2015 and June 2016 in the delta region of Myanmar, are analyzed to determine the risks of STH infection in the whole community over a year which included two MDA rounds.

Trachoma

Ghana eliminates trachoma, freeing millions from suffering and blindness

Collins Boakye-Agyemang
World Health Organization Regional Office for Africa
The World Health Organization (WHO) congratulated Ghana for having eliminated trachoma as a public health problem, two decades after the World Health Assembly resolved to tackle the leading infectious cause of blindness. “It’s been 20 years since the global health community committed to eliminating trachoma worldwide” said WHO Director-General, Dr Tedros Adhanom Ghebreyesus. “Although there’s more work to do elsewhere, the validation of elimination in Ghana allows another previously heavily-endemic country to celebrate significant success.” Ghana is the first country in WHO’s African Region to achieve this milestone.

20 years later: How the World Health Assembly catalyzed momentum to end trachoma

Serge Resnikoff
International Coalition for Trachoma Control
The establishment of the International Coalition for Trachoma Control (ICTC) in 2004 brought together non‐governmental, donor, private sector and academic organizations to support the GET2020 Alliance. By working together, sharing data and ensuring different stakeholders expertise are used strategically; donors recognized that the trachoma community had a real plan and the expertise to achieve elimination.

Opinion: Eliminating trachoma means more than an end to blindness

Caroline Roan and Edridah Muheki Tukahebwa
Devex
For people in communities such as Moroto, a remote district in Northern Uganda, the eye disease trachoma is more than just an affliction associated with pain and irreversible blindness. Caused by a treatable and preventable bacterial infection that spreads through human contact and flies, trachoma acts as a social and economic anchor in the impoverished communities where it typically takes root. It can keep children out of school, prevent adults from working, and trap families in a cycle of poverty.

Trachoma prevention launched in Chinsali

Lusaka Times
Chief Nkula charged that as an advocate of Children’s rights, he will closely monitor the exercise to see to it that all the children in the area have access to the Trachoma drug. He said the efforts by the Ministry of Health are welcome and will support them to ensure the effective implementation of the exercise.

Why do patients refuse trichiasis surgery? Lessons and an education initiative from Mtwara Region, Tanzania

Katherine M. Gupta et al.
PLOS Neglected Tropical Diseases
We used a combination of focus groups, interviews with community health workers, and individual interviews with trichiasis patients who refused surgery to understand their decision-making. We found that several factors influenced surgical refusals, including misconception regarding recovery time, inability to find a post-surgical caregiver, and the time of year of the surgical campaign. Fear of the surgery itself played a minimal role in refusals.

Doctors fear possible trachoma resurgence

The Himalayan
Nepal is the first country in the South East Asia Region to be validated by World Health Organisation for having eliminated trachoma. However, doctors are worried about a possible resurgence of the disease due to the open border with India. “One of the major challenges in keeping the country trachoma-free is the open border with India,” said Dr Tirtha Prasad Mishra, chairman of Nepal Netra Jyoti Sangh. He said the number of Indian nationals visiting eye hospitals in Nepal for treatment was more than Nepali citizens.

Cross-cutting

UC San Diego establishes new Center For Anti-Parasitic Drug Discovery And Development

News Medical Life Sciences
Leveraging its strengths in molecular biology, clinical research and pharmaceutical sciences, the University of California San Diego has now launched a new Center for Anti-Parasitic Drug Discovery and Development to address this unmet need in global health. "These diseases are called 'neglected' because there is little economic incentive for the pharmaceutical industry to intervene," said James McKerrow, MD, PhD, Distinguished Professor, dean of Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego and head of the new center. "Since we are a public university, we have a duty to meet that challenge."

The END Fund 2017 Annual Report

The END Fund
In 2017 alone – with our dedicated partners in 23 countries – we treated more than 97 million people with over 150 million donated treatments valued at close to $260 million, trained more than 345,000 health workers and provided over 1,100 surgeries for advanced elephantiasis and trachoma.

Milestones in Eliminating NTDs

Bill Brieger
Malaria Matters
“Preventive chemotherapy is achievable, as proven by the increasing numbers of people being reached each year. In 2015, over 1.5 billion treatments were administered to almost 1 billion individuals for at least one of the targeted infections: lymphatic filariasis, onchocerciasis, schistosomiasis soil-transmitted helminthiases and trachoma. At a low cost – between US$ 0.30 and US$ 0.50 per person treated in most settings – preventive chemotherapy remains the most affordable, cost-effective strategy for controlling and eliminating these diseases,” explains the World Health Organization.

Many Neglected Tropical Diseases: What About Eliminating Them?

Bill Brieger
Malaria Matters
Based on the World Health Organization’s 2020 Roadmap on NTDs, the London Declaration on NTDs recognized a “tremendous opportunity to control or eliminate at least 10 of these devastating diseases by the end of the decade” (i.e. by 2020). These include eradication of Guinea worm disease, and elimination by 2020 of lymphatic filariasis (LF), leprosy, sleeping sickness {human African trypanosomiasis) and blinding trachoma.

Other

A clinical trial to find a new treatment for visceral leishmaniasis begins in eastern Africa

Africa Science News
A new study to find a safer, efficacious and more patient-friendly treatment and improved diagnostic tools for people living with visceral leishmaniasis (VL) begun in eastern Africa. The study is within the new wider Afri-KA-DIA Consortium that got funding from The European & Developing Countries Clinical Trials Partnership (EDCTP).

Genetic polymorphism in Leishmania infantum isolates from human and animals determined by nagt PCR-RFLP

Adil El Hamouchi, Sofia El Kacem, Rajaa Ejghal and Meryem Lemrani
Infectious Diseases of Poverty
Leishmania infantum is the causative agent of human visceral leishmaniasis (VL) and sporadic human cutaneous leishmaniasis (CL) in the Mediterranean region. The main objective of this study was to explore the genetic polymorphism in L. infantum isolates from human and animal hosts in different regions of Morocco.

Three killed by kala-azar as two hospitalised in Marsabit

Irene Mwendwa
Daily Nation (Kenya)
Three people have died of kala-azar in Marsabit County while two others are hospitalised at Marsabit Referral Hospital. The county has been battling kala-azar since last year where more than five people lost their lives and more than 60 others were treated. “Some come in for treatment late while others do not make it to the hospitals. Kala-azar is a disease we can control and avoid deaths but our people are still ignorant,” said Adano Kochi, County Director of Public Health.

Youth participatory research and evaluation to inform a Chagas disease prevention program in Ecuador

Belén Marco-Crespo et al.
Evaluation and Program Planning
This qualitative study engaged a group of young people in participatory research and evaluation activities in order to study to what extent engaging youth in health interventions can inform research and evaluation processes. The results of this study suggest that by demystifying research and evaluation practices and rendering them accessible and relevant, marginalized youth can develop critical and reflexive thinking skills that could be useful for decision-making on health promotion.

Nearly Eradicated in Humans, the Guinea Worm Finds New Victims: Dogs

Donald G. McNeil Jr.
New York Times
We ask the village chief, Moussa Kaye, 87, the last time one of his people had a worm. “Not since 40 years ago,” he says. In this arid central African country, the long global struggle to eliminate a horrifying human parasite has encountered a serious setback: dogs. They are being infected with Guinea worms, and no one knows how.

Artemisinin and its derivatives in treating helminthic infections beyond schistosomiasis

Nelson Siukei Lam, Xinxin Long, Xin-zhuan Su and Fangli Lu
Pharmacological Research
Artemisinin (ART) and its derivatives have been widely used to treat malaria and other protozoan infections; they also possess activities against helminths. So far, many papers on ART and its derivatives against schistosomal infections have been reported and reviewed. This review attempts to summarize recent advances in the uses of ART and its derivatives to treat infections of helminth parasites other than Schistosoma spp. in both humans and animals, including nematodes, cestodes, trematodes, and monogenea parasites.

Curing leprosy worldwide

Daniel Evans
LaGrange News
Health was the focus of Tuesday’s LaGrange-Troup County Chamber of Commerce Early Bird Breakfast. The guest speaker was Dr. David Addiss from the Task Force for Global Health. He currently serves as the Task Force’s Director of the Focus Area for Compassion and Ethics and Senior Advisor to the Global Partnership for Zero Leprosy. “Global health is local health, so the health issues that are important to you are important at the global level,” Addiss said. “The solutions from those problems may come from in the community and outside. That’s why this idea that we are all in this together is so fundamental.”

Barriers to trypanosome transmission by tsetse flies

Hilary Hurd
BugBitten
Only a small percentage of tsetse flies end up with salivary gland infections. Events that occur in the cardia are crucial in determining whether the fly will transmit infection to another human, but the barriers that prevent salivary gland infections are not understood. Recently, Aurélien Vigneron and colleagues reported their comprehensive investigation of molecular and cellular mechanisms in the cardia that might inhibit salivary gland invasion.

Use of Bead-Based Serologic Assay to Evaluate Chikungunya Virus Epidemic, Haiti

Eric W. Rogier et al.
Emerging Infectious Diseases
The index case of chikungunya virus (CHIKV) in Haiti was reported during early 2014; the vector, the pervasive Aedes aegypti mosquito, promoted rapid spread throughout the country. During December 2014–February 2015, we collected blood samples from 4,438 persons at 154 sites (62 urban, 92 rural) throughout Haiti and measured CHIKV [Immunoglobin G, or] IgG by using a multiplex bead assay. Our findings demonstrated through serologic testing the recent and rapid dissemination of the arbovirus throughout the country. These results show the utility of serologic data to conduct epidemiological studies of quickly spreading mosquito-borne arboviruses.

Could A Single Vaccine Prevent Multiple Diseases Spread By Mosquitoes?

Alex Berezow
American Council on Science and Health
Mosquitoes transmit a wide variety of nasty microbes, from viruses like dengue, yellow fever, and Zika to parasites like malaria. The sheer number and diversity of diseases transmitted by mosquitoes makes vaccine development a challenge. But what if a vaccine could target the mosquito, instead? That's the idea presented by the NIH's Dr. Jessica Manning and her colleagues.

Pathway to Deployment of Gene Drive Mosquitoes as a Potential Biocontrol Tool for Elimination of Malaria in Sub-Saharan Africa

Stephanie James et al.
The American Journal of Tropical Medicine and Hygiene
Gene drive technology offers the promise for a high-impact, cost-effective, and durable method to control malaria transmission that would make a significant contribution to elimination. Progression through the testing pathway is based on fulfillment of safety and efficacy criteria, and is subject to regulatory and ethical approvals, as well as social acceptance. The working group identified several resources that were considered important to support responsible field testing of gene drive mosquitoes.

Impact of climate variability on the transmission risk of malaria in northern Côte d'Ivoire

Richard K. M'Bra et al.
PLOS One
Since the 1970s, the northern part of Côte d'Ivoire has experienced considerable fluctuation in its meteorology including a general decrease of rainfall and increase of temperature from 1970 to 2000, a slight increase of rainfall since 2000, a severe drought in 2004–2005 and flooding in 2006–2007. Such changing climate patterns might affect the transmission of malaria. The purpose of this study was to analyze climate and environmental parameters associated with malaria transmission in Korhogo, a city in northern Côte d’Ivoire.

Ugandan wins Africa prize for bloodless malaria test

BBC News
Brian Gitta, 24, won the Royal Academy of Engineering's Africa Prize for a device that detects tell-tale signs of malaria by shining a red beam of light on the patient's finger. The diagnosis is ready to be shared to a mobile phone in a minute. He developed the device, called Matibabu, after blood tests failed to diagnose his own malaria.

Upcoming Events 

Snakebite: From Science to Society
June 21-22, Leiden, the Netherlands
Naturalis Biodiversity Center
Naturalis organises a 2-day international conference ‘Snakebite : from science to society’ to draw attention to a devastating, neglected tropical disease and to ignite international action on snakebite prevention and treatment. By bringing together science, government, industry and societal & humanitarian aid organisations, we want to take the first steps in developing solutions for the issues concerning snakebites in the tropics.

ISNTD d³
June 25-26, London, UK
ISNTD d3 will bring togther experts from within drug discovery and clinical trials to drive the debate and foster new partnerships & alliances leading to tangible outcomes in terms of new therapies to combat these diseases.

ITI Trachoma Expert Committee Meeting
June 26-28, Atlanta, Georgia
International Trachoma Initiative's Trachoma Expert Committee Meeting is an independent body of internationally recognized experts that meets twice annually to review country applications for donations of Zithromax®. 

Eradicate Malaria World Congress 2018
July 1-5,  Melbourne, Australia
The inaugural World Congress on Malaria - Eradicate Malaria 2018 - will bring together the broad global community including implementers, scientists, funders, governments, policy makers and those directly affected by the disease. The aim is to bring the broad spectrum of the malaria world together for the first time, to further galvanise the effort for the eradication of malaria.

Science in the City: Neglected Tropical Diseases
July 10,  Seattle, Washington
Julie Jacobson, Senior Program Officer, Global Health with The Bill & Melinda Gates Foundation will discuss controlling neglected tropical diseases. This free even is part of the Pacific Science Center's Global Health and Development lecture series, in partnership with the Bill & Melinda Gates Foundation and WGHA.

MSF Scientific Days - South Asia 2018
July 16,  New Delhi, India
MSF Scientific Days - South Asia is a conference to showcase research, innovation, and experiences from treatment and humanitarian programmes across the region. The conference provides a platform for stakeholders – health groups, vulnerable communities and treatment providers - to share knowledge and help improve quality of care provided to patients & populations.

5th International Conference on Neglected Tropical & Infectious Diseases
August 29-30,  Boston, Massachussetts
Theme: Uniting all to overcome and fight against NTD's & infectious diseases for improved health protection.

2018 ROP Africa Symposium
September 3-4,  Cape Town, South Africa
The International Paediatric Ophthalmology and Strabismus Council and The Department of Pediatric Ophthalmology at The Red Cross War Memorial Children’s Hospital, Cape Town are proud to announce the 2018 ROP Africa Symposium.

First International Podoconiosis Conference
September 23, Addis Ababa, Ethiopia
The theme for this is ‘Research to Implementation: A Call for Global Action’. With this invitation to register, we are also calling for abstracts from all those involved in podoconiosis research and implementation. In order to stimulate high levels of participation, the conference programme will include two sessions of research presentations, one of implementation presentations, and a poster display area. Abstracts for each of these will be selected by competitive process, and prizes will be awarded for the best research and the best implementation presentations. Travel awards will be available for a limited number of selected abstracts.

NNN 2018 
September 24-26, Addis Ababa, Ethiopia
We are delighted to announce the dates for the 9th NNN annual conference, subject to venue availability.

10th Euro-Global Conference on Infectious Diseases
September 27-29, Rome, Italy
Theme: Advancing in science and improving care to prevent infectious diseases.

International Conference on Migration Health
October 1-3, Rome, Italy
Hosted by the international Society of Travel Medicine.

World Sight Day
October 11, 2018
World Sight Day (WSD) is an annual day of awareness held on the second Thursday of October, to focus global attention on blindness and vision impairment. This year, the "Call to Action" for World Sight Day is "Eye Care Everywhere."

67th Annual ASTMH Meeting 
October 28 - November 1, New Orleans, Louisiana
The ASTMH Annual Meeting draws tropical medicine and global health professionals representing academia, government, non-profits, philanthropy, NGOs, industry, military and private practice. The meeting is designed for researchers, professors, government and public health officials, military personnel, travel clinic physicians, practicing physicians in tropical medicine, students and all health care providers working in the fields of tropical medicine, hygiene and global health. 

7th Global Scabies Control Meeting
October 28, New Orleans, Louisiana
We are pleased to announce the date for the 7th Global Scabies Control meeting. The meeting will be held on Sunday 28th October in New Orleans, LA, USA. Please mark this in your diaries now! Further information and registration details will follow in coming months. 

1st International Caparica Congress on Leishmaniasis
October 29-31, Caparica, Portugal
This conference intends to gather researchers working in areas related to Leishmaniasis, from treatment to prevention. In fact, as leishmaniasis is slowly but constantly, increasing worldwide, this conference is addressed to show the latest research trends in this area. The idea is to push forward the battle against this persistent disease. 

Vector-Borne Diseases in the UK - Biennial Meeting, 2018
December 3-4, Norwich, UK
This meeting will be the fourth we have held on this topic, with previous meetings in 2012, 2014 and 2016, and like before we will bring together members of the major UK research groups who have an interest in vectors or vector-borne diseases which could be a threat to the UK; groups with wider but related areas of interest; members of key UK Government Departments and their Agencies; and representatives of European organisations with an interest in this topic. 

Women Deliver 2019 Conference 
June 3-6, 2019, Vancouver, Canada
The Women Deliver 2019 Conference – the world’s largest gathering on the health, rights, and wellbeing of women and girls – will serve as a fueling station for advocates working to achieve a more gender equal world. In the summer of 2019, over 6,000 world leaders, influencers, advocates, academics, activists, and journalists will flock to Vancouver with dreams of accelerating progress girls and women everywhere.